Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?

Bright Minds Biosciences Inc. (DRUG) faces a consensus price target implying 107.5% upside, though the article notes this metric is of limited effectiveness. The more actionable near-term signal is an upward trend in earnings estimate revisions, which may support further stock upside.

Analysis

Bright Minds Biosciences Inc. (DRUG) faces a consensus price target implying 107.5% upside, though the article notes this metric is of limited effectiveness. The more actionable near-term signal is an upward trend in earnings estimate revisions, which may support further stock upside.